- Home
- PLCE vs KRRO Comparison
PLCE vs KRRO Comparison
Compare PLCE & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLCE | KRRO |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.2M | 105.0M |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLCE | KRRO |
|---|---|---|
| Price | $3.69 | $11.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $4.50 | ★ $47.10 |
| AVG Volume (30 Days) | ★ 242.7K | 151.5K |
| Earning Date | 01-01-0001 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.35 | ★ 82.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,271,000.00 |
| Revenue This Year | N/A | $145.97 |
| Revenue Next Year | $1.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.65 | $5.20 |
| 52 Week High | $9.56 | $55.89 |
Technical Indicators
Market Signals| Indicator | PLCE | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 50.82 |
| Support Level | N/A | $10.55 |
| Resistance Level | $4.79 | $12.54 |
| Average True Range (ATR) | 0.20 | 0.78 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 5.53 | 45.29 |
Price Performance
Historical ComparisonAbout PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.